• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内溶酶体网络在胆固醇稳态和代谢相关脂肪性肝病(MAFLD)中的功能。

Function of the endolysosomal network in cholesterol homeostasis and metabolic-associated fatty liver disease (MAFLD).

机构信息

Department of Pediatrics, section Molecular Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Department of Pediatrics, section Molecular Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

出版信息

Mol Metab. 2021 Aug;50:101146. doi: 10.1016/j.molmet.2020.101146. Epub 2021 Jan 5.

DOI:10.1016/j.molmet.2020.101146
PMID:33348067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8324686/
Abstract

BACKGROUND

Metabolic-associated fatty liver disease (MAFLD), also known as non-alcoholic fatty liver disease, has become the leading cause of chronic liver disease worldwide. In addition to hepatic accumulation of triglycerides, dysregulated cholesterol metabolism is an important contributor to the pathogenesis of MAFLD. Maintenance of cholesterol homeostasis is highly dependent on cellular cholesterol uptake and, subsequently, cholesterol transport to other membrane compartments, such as the endoplasmic reticulum (ER).

SCOPE OF REVIEW

The endolysosomal network is key for regulating cellular homeostasis and adaptation, and emerging evidence has shown that the endolysosomal network is crucial to maintain metabolic homeostasis. In this review, we will summarize our current understanding of the role of the endolysosomal network in cholesterol homeostasis and its implications in MAFLD pathogenesis.

MAJOR CONCLUSIONS

Although multiple endolysosomal proteins have been identified in the regulation of cholesterol uptake, intracellular transport, and degradation, their physiological role is incompletely understood. Further research should elucidate their role in controlling metabolic homeostasis and development of fatty liver disease.

摘要

背景

代谢相关脂肪性肝病(MAFLD),又称非酒精性脂肪性肝病,已成为全球慢性肝病的主要病因。除了肝内甘油三酯蓄积外,胆固醇代谢失调也是 MAFLD 发病机制的重要因素。胆固醇稳态的维持高度依赖于细胞摄取胆固醇,随后将胆固醇转运至其他膜区室,如内质网(ER)。

综述范围

内体溶酶体网络对于调节细胞内稳态和适应具有关键作用,新出现的证据表明,内体溶酶体网络对于维持代谢稳态至关重要。在这篇综述中,我们将总结我们对内体溶酶体网络在胆固醇稳态中的作用及其在 MAFLD 发病机制中的意义的现有认识。

主要结论

尽管已经确定了多种内体溶酶体蛋白在胆固醇摄取、细胞内转运和降解的调节中发挥作用,但它们的生理作用尚不完全清楚。进一步的研究应阐明它们在控制代谢稳态和脂肪性肝病发展中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/8324686/57c28fd3bfd1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/8324686/5b4e3ea9a01d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/8324686/57c28fd3bfd1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/8324686/5b4e3ea9a01d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/8324686/57c28fd3bfd1/gr2.jpg

相似文献

1
Function of the endolysosomal network in cholesterol homeostasis and metabolic-associated fatty liver disease (MAFLD).内溶酶体网络在胆固醇稳态和代谢相关脂肪性肝病(MAFLD)中的功能。
Mol Metab. 2021 Aug;50:101146. doi: 10.1016/j.molmet.2020.101146. Epub 2021 Jan 5.
2
Metabolic-associated fatty liver disease and lipoprotein metabolism.代谢相关性脂肪性肝病与脂蛋白代谢。
Mol Metab. 2021 Aug;50:101238. doi: 10.1016/j.molmet.2021.101238. Epub 2021 Apr 20.
3
Polyribonucleotide nucleotidyltransferase 1 participates in metabolic-associated fatty liver disease pathogenesis by affecting lipid metabolism and mitochondrial homeostasis.多聚核糖核苷酸核苷酸转移酶 1 通过影响脂质代谢和线粒体稳态参与代谢相关脂肪性肝病发病机制。
Mol Metab. 2024 Nov;89:102022. doi: 10.1016/j.molmet.2024.102022. Epub 2024 Aug 31.
4
Loss and gain of function of Grp75 or mitofusin 2 distinctly alter cholesterol metabolism, but all promote triglyceride accumulation in hepatocytes.Grp75 或线粒体融合蛋白 2 的功能丧失或获得,均可明显改变胆固醇代谢,但均促进肝细胞内甘油三酯的蓄积。
Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Dec;1866(12):159030. doi: 10.1016/j.bbalip.2021.159030. Epub 2021 Aug 20.
5
Neutrophil: An emerging player in the occurrence and progression of metabolic associated fatty liver disease.中性粒细胞:代谢相关脂肪性肝病发生发展中的一个新角色。
Int Immunopharmacol. 2021 Aug;97:107609. doi: 10.1016/j.intimp.2021.107609. Epub 2021 Apr 19.
6
An optical nanoreporter of endolysosomal lipid accumulation reveals enduring effects of diet on hepatic macrophages in vivo.一种内溶酶体脂质积累的光学纳米报告器揭示了饮食对体内肝巨噬细胞的持久影响。
Sci Transl Med. 2018 Oct 3;10(461). doi: 10.1126/scitranslmed.aar2680.
7
SIMPLE Is an Endosomal Regulator That Protects Against NAFLD by Targeting the Lysosomal Degradation of EGFR.SIMPLE是一种内体调节因子,通过靶向表皮生长因子受体(EGFR)的溶酶体降解来预防非酒精性脂肪性肝病(NAFLD)。
Hepatology. 2021 Dec;74(6):3091-3109. doi: 10.1002/hep.32075. Epub 2021 Nov 2.
8
High susceptibility to fatty liver disease in two-pore channel 2-deficient mice.两孔通道 2 缺陷小鼠对脂肪肝疾病的高易感性。
Nat Commun. 2014 Aug 21;5:4699. doi: 10.1038/ncomms5699.
9
Deranged hepatocyte intracellular Ca homeostasis and the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma.肝细胞内 Ca 稳态紊乱与非酒精性脂肪性肝病向肝细胞癌的进展。
Cell Calcium. 2019 Sep;82:102057. doi: 10.1016/j.ceca.2019.102057. Epub 2019 Jul 26.
10
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.非酒精性脂肪性肝炎发病机制中的脂质氧化产物。
Free Radic Biol Med. 2017 Oct;111:173-185. doi: 10.1016/j.freeradbiomed.2017.01.023. Epub 2017 Jan 18.

引用本文的文献

1
Novel subtypes of metabolic associated steatotic liver disease linked to clinical outcomes: implications for precision medicine.与临床结局相关的代谢相关脂肪性肝病新亚型:对精准医学的启示
J Transl Med. 2025 Jul 10;23(1):769. doi: 10.1186/s12967-025-06670-5.
2
Unraveling the cGAS/STING signaling mechanism: impact on glycerolipid metabolism and diseases.解析cGAS/STING信号传导机制:对甘油脂质代谢及疾病的影响
Front Med (Lausanne). 2024 Nov 28;11:1512916. doi: 10.3389/fmed.2024.1512916. eCollection 2024.
3
High-density lipoprotein cholesterol trajectory and new-onset metabolic dysfunction-associated fatty liver disease incidence: a longitudinal study.

本文引用的文献

1
A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export.三聚体 Rab7 GEF 控制 NPC1 依赖性溶酶体胆固醇输出。
Nat Commun. 2020 Nov 3;11(1):5559. doi: 10.1038/s41467-020-19032-0.
2
Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran).用于预防动脉粥样硬化性心血管疾病的低密度脂蛋白胆固醇降低策略:聚焦靶向 PCSK9(inclisiran)的 siRNA 治疗。
Curr Cardiol Rep. 2020 Oct 21;22(12):176. doi: 10.1007/s11886-020-01427-6.
3
Aster Proteins Regulate the Accessible Cholesterol Pool in the Plasma Membrane.
高密度脂蛋白胆固醇轨迹与新发代谢功能障碍相关脂肪性肝病发病率:一项纵向研究。
Diabetol Metab Syndr. 2024 Sep 11;16(1):223. doi: 10.1186/s13098-024-01457-y.
4
Macrophage metabolism in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中的巨噬细胞代谢。
Front Immunol. 2023 Oct 4;14:1257596. doi: 10.3389/fimmu.2023.1257596. eCollection 2023.
5
Adaptive activation of EFNB2/EPHB4 axis promotes post-metastatic growth of colorectal cancer liver metastases by LDLR-mediated cholesterol uptake.EFNB2/EPHB4 轴的适应性激活通过 LDLR 介导的胆固醇摄取促进结直肠癌肝转移的转移后生长。
Oncogene. 2023 Jan;42(2):99-112. doi: 10.1038/s41388-022-02519-z. Epub 2022 Nov 14.
6
Inhibition of Hepatic AMPK Pathway Contributes to Free Fatty Acids-Induced Fatty Liver Disease in Laying Hen.肝脏AMPK信号通路抑制促进蛋鸡游离脂肪酸诱导的脂肪肝疾病
Metabolites. 2022 Sep 1;12(9):825. doi: 10.3390/metabo12090825.
7
Alteration in Rab11-mediated endocytic trafficking of LDL receptor contributes to angiotensin II-induced cholesterol accumulation and injury in podocytes.Rab11 介导的 LDL 受体内吞运输的改变导致血管紧张素 II 诱导的足细胞胆固醇积累和损伤。
Cell Prolif. 2022 Jun;55(6):e13229. doi: 10.1111/cpr.13229. Epub 2022 May 14.
8
Pathways and Mechanisms of Cellular Cholesterol Efflux-Insight From Imaging.细胞胆固醇流出的途径和机制——来自成像技术的见解
Front Cell Dev Biol. 2022 Mar 1;10:834408. doi: 10.3389/fcell.2022.834408. eCollection 2022.
9
ER Disposal Pathways in Chronic Liver Disease: Protective, Pathogenic, and Potential Therapeutic Targets.慢性肝病中的内质网处置途径:保护性、致病性及潜在治疗靶点
Front Mol Biosci. 2022 Jan 31;8:804097. doi: 10.3389/fmolb.2021.804097. eCollection 2021.
10
cGAS‒STING signaling and function in metabolism and kidney diseases.cGAS-STING 信号转导在代谢和肾脏疾病中的作用。
J Mol Cell Biol. 2021 Dec 30;13(10):728-738. doi: 10.1093/jmcb/mjab066.
星状蛋白调节质膜中可及胆固醇池。
Mol Cell Biol. 2020 Sep 14;40(19). doi: 10.1128/MCB.00255-20.
4
Hepatic Rab24 controls blood glucose homeostasis via improving mitochondrial plasticity.肝 Rab24 通过改善线粒体可塑性控制血糖稳态。
Nat Metab. 2019 Oct;1(10):1009-1026. doi: 10.1038/s42255-019-0124-x. Epub 2019 Oct 14.
5
Metabolic coessentiality mapping identifies C12orf49 as a regulator of SREBP processing and cholesterol metabolism.代谢必需性作图鉴定 C12orf49 为 SREBP 加工和胆固醇代谢的调节剂。
Nat Metab. 2020 Jun;2(6):487-498. doi: 10.1038/s42255-020-0206-9. Epub 2020 Jun 1.
6
Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.从头开始的脂肪酸合成的遗传相互作用的系统作图将 C12orf49 鉴定为脂质代谢的调节剂。
Nat Metab. 2020 Jun;2(6):499-513. doi: 10.1038/s42255-020-0211-z. Epub 2020 Jun 1.
7
Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine.LDL 胆固醇从溶酶体到质膜再到内质网的路径中的最后一步受磷脂酰丝氨酸控制。
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18521-18529. doi: 10.1073/pnas.2010682117. Epub 2020 Jul 20.
8
POST1/C12ORF49 regulates the SREBP pathway by promoting site-1 protease maturation.POST1/C12ORF49 通过促进位点 1 蛋白酶成熟来调节 SREBP 通路。
Protein Cell. 2021 Apr;12(4):279-296. doi: 10.1007/s13238-020-00753-3. Epub 2020 Jul 14.
9
Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis.胆固醇稳定肝细胞中的 TAZ 以促进实验性非酒精性脂肪性肝炎。
Cell Metab. 2020 May 5;31(5):969-986.e7. doi: 10.1016/j.cmet.2020.03.010. Epub 2020 Apr 6.
10
Staying in touch with the endocytic network: The importance of contacts for cholesterol transport.保持与内吞网络的联系:胆固醇运输中接触的重要性。
Traffic. 2020 May;21(5):354-363. doi: 10.1111/tra.12726. Epub 2020 Mar 31.